Xifaxan 550 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FJH0Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,093
Award facts
- Contract value 100% obligated
- $22,092.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award from the Defense Logistics Agency (DLA) on January 9, 2026, for the supply of Xifaxan 550 mg tablets in quantities of 60 units. This is a firm fixed-price, non-set-aside contract with a ceiling value of $22,092.67 and an ultimate completion date of January 12, 2026. The place of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate office. Xifaxan is a non-absorbed antibiotic commonly used to treat traveler's diarrhea and other gastrointestinal conditions, representing one component of the extensive pharmaceutical procurement activities managed by DLA for military and federal healthcare systems.
This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive prime vendor contract enables Amerisourcebergen to supply a broad range of pharmaceutical products and medical commodities—including specialty medications, brand-name and generic drugs, vaccines, and related supplies—to support military healthcare programs globally. The parent company, Cencora, Inc., also maintains a separate $999,999,999.00 IDC with DLA through December 31, 2031, demonstrating the company's substantial role in the federal pharmaceutical supply chain serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FJH0Q?
SPE2DR26FJH0Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FJH0Q worth?
The government has obligated $22,093 on SPE2DR26FJH0Q.
Is contract SPE2DR26FJH0Q an order under another contract?
Yes. SPE2DR26FJH0Q is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH0Q competed?
The extent of competition for SPE2DR26FJH0Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award